E. J. Runggaldier

Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients

R. Foà, S. Molica, S. Chiaretti, 2014, American journal of hematology.

Rituximab Plus Chlorambucil As Initial Treatment for Elderly Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Pre-Treatment Biological Characteristics and Gene Expression Patterns on Response to Treatment

R. Foà, S. Molica, S. Chiaretti, 2011 .

A phase II study of chlorambucil plus rituximab followed by maintenance versus observation in elderly patients with previously untreated chronic lymphocytic leukemia: Results of the induction phase.

S. Molica, A. Guarini, A. Cuneo, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Study of Chlorambucil Plus Rituximab Followed by Maintenance Versus Observation In Elderly Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results of the First Interim Analysis

R. Foà, S. Molica, P. Zinzani, 2010 .

Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients

R. Foà, S. Molica, S. Chiaretti, 2014, American journal of hematology.